Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON)

In proton magnetic resonance imaging (MRI) metallic substances lead to magnetic field distortions that often result in signal voids in the adjacent anatomic structures. Thus, metallic objects and superparamagnetic iron oxide (SPIO)‐labeled cells appear as hypointense artifacts that obscure the under...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance in medicine Vol. 58; no. 5; pp. 1072 - 1077
Main Authors Stuber, Matthias, Gilson, Wesley D., Schär, Michael, Kedziorek, Dorota A., Hofmann, Lawrence V., Shah, Saurabh, Vonken, Evert-Jan, Bulte, Jeff W.M., Kraitchman, Dara L.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In proton magnetic resonance imaging (MRI) metallic substances lead to magnetic field distortions that often result in signal voids in the adjacent anatomic structures. Thus, metallic objects and superparamagnetic iron oxide (SPIO)‐labeled cells appear as hypointense artifacts that obscure the underlying anatomy. The ability to illuminate these structures with positive contrast would enhance noninvasive MR tracking of cellular therapeutics. Therefore, an MRI methodology that selectively highlights areas of metallic objects has been developed. Inversion‐recovery with ON‐resonant water suppression (IRON) employs inversion of the magnetization in conjunction with a spectrally‐selective on‐resonant saturation prepulse. If imaging is performed after these prepulses, positive signal is obtained from off‐resonant protons in close proximity to the metallic objects. The first successful use of IRON to produce positive contrast in areas of metallic spheres and SPIO‐labeled stem cells in vitro and in vivo is presented. Magn Reson Med 58:1072–1077, 2007. © 2007 Wiley‐Liss, Inc.
Bibliography:Biomedical Engineering Grant, Whitaker Foundation - No. RG-02-0745
National Institutes of Health (NIH) - No. RO1 HL084186; No. RO1 HL061912; No. RO1 HL073223; No. RO1 NS045062; No. RO1 K08 EB004922
ark:/67375/WNG-JRJ6P1JN-H
istex:69C9A0C37A6E29F0E6814E457F9FBFEA2560EBE3
ArticleID:MRM21399
Matthias Stuber is compensated as a consultant by Philips Medical Systems NL, the manufacturer of equipment described in this presentation. The terms of this arrangement have been approved by the Johns Hopkins University in accordance with its conflict of interest policies.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0740-3194
1522-2594
DOI:10.1002/mrm.21399